Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Zydus Hospitals And Medical Research Pri Vate Limited, was an unlisted private company incorporated on 13 February, 2008. It is classified as a private limited company and is located in , Gujarat. It's authorized share capital was INR 11.00 cr and the total paid-up capital was INR 1.00 lac.
The current status of Zydus Hospitals And Medical Research Pri Vate Limited is - Amalgamated.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Mukesh Raojibhai Patel | 00032104 | 17 years |
| Director | Pankaj Ramanbhai Patel | 00131852 | 17 years |
| Director | Sharvil Pankajbhai Patel | 00131995 | 17 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| BAAP DIAGNOSTICS LIMITED |
Amalgamated
|
5.0 L | 1 | Gujarat |
| MABS BIOTECH PRIVATE LIMITED |
Converted to LLP
|
5.0 L | 2 | Gujarat |
| ZANDRA INFRASTRUCTURE PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 1 | Gujarat |
| SOLVIUS LLP |
Active
|
1.0 Cr | 1 | Gujarat |
| XYLOPIA LABS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
| CADMACH MACHINERY COMPANY PRIVATE LIMITED |
Active
|
22.2 L | 3 | Gujarat |
| CADILA LABORATORIES PRIVATE LIMITED |
Active
|
3.8 Cr | 2 | Gujarat |
| BAYER CROPSCIENCE LIMITED |
Active
|
44.9 Cr | 1 | Maharashtra |
| PRIPAN INVESTMENT PRIVATE LIMITED |
Active
|
286.2 Cr | 2 | Gujarat |
| ZYDUS HOSPITALS (VADODRA) PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 2 | Gujarat |
| ZYDUS HOSPITALS (RAJKOT) PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 2 | Gujarat |
| GRUH FINANCE LIMITED |
Amalgamated
|
146.8 Cr | 1 | Gujarat |
| ZYDUS BSV RESEARCH AND DEVELOPMENT PRIVA TE LIMITED |
Amalgamated
|
2.0 Cr | 1 | Gujarat |
| ZYDUS FOUNDATION |
Active
|
5.0 L | 2 | Gujarat |
| ZYDUS LIFESCIENCES LIMITED |
Active
|
100.6 Cr | 2 | Gujarat |
| WESTERN AHMEDABAD EFFLUENT CONVEYANCE COMPANY PRIVATE LIMITED |
Active
|
1.0 L | 2 | Gujarat |
| ZYDUS HEALTHCARE LIMITED |
Amalgamated
|
10.0 Cr | 2 | Gujarat |
| CADILA LIFESCIENCES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Gujarat |
| ZANDRA HERBS AND PLANTATIONS LLP |
Active
|
1.0 Cr | 2 | Gujarat |
| RAJNIGANDHA DEVELOPERS LLP |
Active
|
1.0 L | 2 | Gujarat |
| VERTIUS LLP |
Active
|
10.0 L | 1 | Gujarat |
| ZANDRA INFRASTRUCTURE LLP |
Active
|
1.0 L | 2 | Gujarat |
| ZYDUS HOSPITAL LLP |
Active
|
10.0 L | 2 | Gujarat |
| ALETA HOSPITALS LLP |
Active
|
1.0 L | 2 | Gujarat |
| ZENILA VENTURES LLP |
Active
|
5.0 L | 2 | Gujarat |
| ZYDUS HOSPITALS AND HEALTHCARE RESEARCH PRIVATE LIMITED |
Active
|
1.0 L | 2 | Gujarat |
| ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED |
Active
|
20.0 Cr | 1 | Maharashtra |
| GREAT EASTERN ENERGY CORPORATION LIMITED |
Active
|
59.6 Cr | 1 | West Bengal |
| INVEST INDIA |
Active
|
1.0 Cr | 1 | Delhi |
| NIRMA LIMITED |
Active
|
73.0 Cr | 1 | Gujarat |
| DIALFORHEALTH INDIA LIMITED |
Amalgamated
|
25.0 Cr | 1 | Gujarat |
| ZYDUS ANIMAL HEALTH LIMITED |
Amalgamated
|
24.0 Cr | 1 | Gujarat |
| LIVA NUTRITIONS LIMITED |
Active
|
3.0 Cr | 1 | Gujarat |
| LIVA INVESTMENT LIMITED |
Active
|
25.0 L | 1 | Gujarat |
| ZYDUS PHARMACEUTICALS LIMITED |
Amalgamated
|
95.0 L | 1 | Gujarat |
| ZYDUS TECHNOLOGIES LIMITED |
Amalgamated
|
59.0 Cr | 1 | Gujarat |
| ZYDUS WELLNESS LIMITED |
Active
|
63.6 Cr | 1 | Gujarat |
| ZYDUS HEALTHCARE LIMITED |
Active
|
21.6 Cr | 1 | Gujarat |
| ZYDUS WELLNESS PRODUCTS LIMITED |
Active
|
218.8 Cr | 1 | Gujarat |
| HEINZ INDIA PRIVATE LIMITED |
Amalgamated
|
10.4 Cr | 1 | Gujarat |
The incorporation date of ZYDUS HOSPITALS AND MEDICAL RESEARCH PRI VATE LIMITED is 13 February, 2008
The authorized share capital of ZYDUS HOSPITALS AND MEDICAL RESEARCH PRI VATE LIMITED is INR ₹ 11.0 Cr.
The paid-up capital of ZYDUS HOSPITALS AND MEDICAL RESEARCH PRI VATE LIMITED is INR ₹ 1.0 L.
The registered address of ZYDUS HOSPITALS AND MEDICAL RESEARCH PRI VATE LIMITED is "ZYDUS TOWER" SATELLITE CROSS ROADS AHMEDABAD Ahmedabad Gujarat - 380015
The CIN number of ZYDUS HOSPITALS AND MEDICAL RESEARCH PRI VATE LIMITED is U85110GJ2008PTC052902.
Expand
Delete
Collapse
See
details
